Skip to main content

Table 2 Subject demographics, CSF marker levels, and neuropsychological test scores by CSF profile

From: Association of glial and neuronal degeneration markers with Alzheimer’s disease cerebrospinal fluid profile and cognitive functions

 

CSF profile

 

Non-AD

T-tau/Aβ42 ≤ 0.52

(n = 24)

AD

T-tau/Aβ42 > 0.52

(n = 28)

p valuea

Demographics

  Gender (M/F)

16/8

17/11

0.66

  Age, years

67 (46–80)

70 (51–84)

0.17

  Education, years

14.0 (9–20)

12.5 (6–17)

0.11

Clinical diagnosis

  SCI/MCI/AD/LBD

10/13/0/1

2/9/16/1

N/Ab

CSF measures

  Aβ42 (pg/ml)

703 (374–2332)

454 (160–822)

N/Ac

  T-tau (pg/ml)

173 (100–722)

416 (132–838)

N/Ac

  NFL (ng/ml)

1.9 (0.9–6.5)

2.5 (1.2–4.5)

0.15

  YKL-40 (ng/ml)

165 (83–399)

203 (124–367)

0.12

  S100B (pg/ml)

215 (132–335)

230 (129–458)

0.17

  GFAP (ng/ml)

1.0 (0.1–7.1)

1.3 (0.5–21.3)

0.09

Cognitive domains

Global cognition

  MMSE, score

28 (24–30)

27 (24–30)

0.01

Verbal episodic memory

  RAVLT immediate recall, score

36 (23–66)

26.5 (13–51)

0.003

  RAVLT delayed recall, score

6.5 (0–15)

1.5 (0–12)

< 0.001

  RAVLT recognition-fp, score

9.0 (3–15)

5.5 (−3–15)

0.003

  Story immediate recall, score

13.5 (5–17)

8 (1–18)

0.005

  Story delayed recall, score

12.0 (1–19)

5.5 (0–16)

0.002

Non-verbal episodic memory

  ROCF immediate recall, score

13.3 (0–27)

7.3 (0–26)

0.04

  ROCF delayed recall, score

12.8 (0–25)

8.5 (0–26)

0.07

Language

  Verbal fluency animal, score

20 (8–33)

14 (4–27)

0.02

  Verbal fluency H+S, score

24.0 (14–48)

25.5 (6–63)

1.00

Processing speed

  TMT-A, seconds

43.5 (21–133)

48.0 (27–116)

0.22

  Stroop—part I, seconds

23.5 (20–42)

24.5 (17–34)

0.64

Executive functions

  TMT-B, seconds

109 (44–340)

153 (60–343)

0.06

  DSST, score

8.5 (3–51)

7.0 (2–61)

0.24

  Stroop 4th/3rd part, seconds

2.1 (1.4–4.0)

2.1 (1.6–5.8)

0.25

  1. Abbreviations: AD Alzheimer’s disease, CSF cerebrospinal fluid, DDST Digit Symbol Substitution Test, fp false positives, LBD Lewy body dementia, MCI mild cognitive impairment, MMSE Mini-Mental State Examination, N/A not applicable, RAVLT Rey Auditory-Verbal Learning Test, ROCF Rey–Osterrieth complex figure, SCI subjective cognitive impairment, TMT Trail Making Test
  2. Values are shown as median (range) or as numbers per group, aMann-Whitney U non-parametric tests used for continuous variables and chi-square tests for categorical variables, p values not applicable for bclinical diagnosis due to CSF profiles being part of the diagnostic criteria for AD and c42 and T-tau due to their values used for defining CSF profiles